Differences in prostate cancer treatment receipt and timeliness of treatment between African American/Black and White Iowans.

ABSTRACT:

Background

Non-Hispanic Black (NHB) men face higher prostate cancer (PCa) mortality rates compared to other racial/ethnic groups. Factors contributing to these disparities, particularly concerning healthcare system factors, remain uncertain. We investigate differences in treatment receipt and timeliness between NHB, non-Hispanic White (NHW) and Hispanic Iowans, examining variations across treatment facilities.

Methods

Demographic, tumor, treatment, and hospital characteristics of PCa patients 40-99 years were obtained from the Iowa Cancer Registry (2010-2020). We used logistic regression to estimate the odds of receiving definitive treatment, time to treatment, and the type of treatment received.

Results

Among 18,747 PCa patients, 18,197 (97.1%) were NHW, 550 (2.9%) N

SUBMITTER: Williams GJ 

PROVIDER: S-EPMC12630164 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature